{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:58:55Z","timestamp":1762113535515},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CSIR-EMR-II (Council of Scientific Research-Extra Mural Research) project and OU-DST-PURSE (Osmania University-Department of Science and Technology-PURSE) programme, Osmania University","award":["CSIR-EMR-II project (vide no-027\/ (0258)\/12\/EMR-II)"],"award-info":[{"award-number":["CSIR-EMR-II project (vide no-027\/ (0258)\/12\/EMR-II)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s13277-015-4295-0","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T07:45:49Z","timestamp":1447400749000},"page":"5475-5484","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of promoter polymorphisms of Fas \u2013FasL genes with development of Chronic Myeloid Leukemia"],"prefix":"10.1007","volume":"37","author":[{"given":"Prajitha Mohandas","family":"Edathara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjula","family":"Gorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailaja","family":"Kagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sugunakar","family":"Vuree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Cingeetham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhoshi Rani","family":"Nanchari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phanni bhushann","family":"Meka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Annamaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghunadha Rao","family":"Digumarthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnupriya","family":"Satti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,13]]},"reference":[{"key":"4295_CR1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/sj.leu.2402577","volume":"16","author":"AS Shet","year":"2002","unstructured":"Shet AS, Jahagirdar BN, Verfaillie CM. Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia. 2002;16:1402\u201311.","journal-title":"Leukemia"},{"issue":"12","key":"4295_CR2","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V96.12.3915","volume":"96","author":"M Cirinna","year":"2000","unstructured":"Cirinna M, Trotta R, Salomoni P, Kossev P, Wasik M, et al. Bcl-2 expression restores the leukemogenic potential of a BCR\/ABL mutant defective in transformation. Blood. 2000;96(12):3915\u201321.","journal-title":"Blood"},{"key":"4295_CR3","doi-asserted-by":"crossref","first-page":"1449e56","DOI":"10.1126\/science.7533326","volume":"267","author":"S Nagata","year":"1995","unstructured":"Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449e56.","journal-title":"Science"},{"key":"4295_CR4","first-page":"312e25","volume":"78","author":"M Muschen","year":"2002","unstructured":"Muschen M, Warskulat U, Beckmann MW. Defining CD95 as a tumor suppressor gene. J Mol Med. 2002;78:312e25.","journal-title":"J Mol Med"},{"key":"4295_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0031-6865(99)00038-2","volume":"74","author":"P Schneider","year":"2000","unstructured":"Schneider P, Tschopp J. Apoptosis induced by death receptors. Pharm Acta Helv. 2000;74:281\u20136.","journal-title":"Pharm Acta Helv"},{"key":"4295_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/1096-911X(20010101)36:1<111::AID-MPO1026>3.0.CO;2-3","volume":"36","author":"N Gross","year":"2001","unstructured":"Gross N, Balmas K, Beretta BC, Tschopp J. Expression of Fas (APO-1\/CD95) and Fas ligand (FasL) in human neuroblastoma. Med Pediatr Oncol. 2001;36:111\u20134.","journal-title":"Med Pediatr Oncol"},{"key":"4295_CR7","doi-asserted-by":"crossref","first-page":"1169e78","DOI":"10.1016\/0092-8674(93)90326-L","volume":"75","author":"T Suda","year":"1993","unstructured":"Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75:1169e78.","journal-title":"Cell"},{"key":"4295_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0161-5890(97)00081-3","volume":"34","author":"QR Huang","year":"1997","unstructured":"Huang QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1\/Fas (CD95) gene. Mol Immunol. 1997;34:577\u201382.","journal-title":"Mol Immunol"},{"key":"4295_CR9","first-page":"4327","volume":"63","author":"K Sibley","year":"2003","unstructured":"Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res. 2003;63:4327\u201330.","journal-title":"Cancer Res"},{"key":"4295_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4049\/jimmunol.170.1.132","volume":"170","author":"J Wu","year":"2003","unstructured":"Wu J, Metz C, Xu X, Abe R, Gibson AW, et al. A novel polymorphic CAAT\/enhancer-binding protein element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol. 2003;170:132\u20138.","journal-title":"J Immunol"},{"key":"4295_CR11","first-page":"141","volume":"59","author":"W Zhang","year":"2012","unstructured":"Zhang W, Li C, Wang J, He C. Functional polymorphisms in FAS\/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma. Hepato-Gastroenterology. 2012;59:141\u20136.","journal-title":"Hepato-Gastroenterology"},{"key":"4295_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053075","volume":"8","author":"M Hashemi","year":"2013","unstructured":"Hashemi M, Fazaeli A, Ghavami S, Eskandari NE, Arbabi F, et al. Functional polymorphisms of FAS and FASL gene and risk of breast cancer -pilot study of 134 cases. PLoS One. 2013;8, e53075.","journal-title":"PLoS One"},{"key":"4295_CR13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/carcin\/bgr211","volume":"32","author":"H Bye","year":"2011","unstructured":"Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, et al. Population specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis. 2011;32:1855\u201361.","journal-title":"Carcinogenesis"},{"key":"4295_CR14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2010.01.003","volume":"58","author":"A Qureshi","year":"2010","unstructured":"Qureshi A, Nan H, Dyer M, Han J. Polymorphisms of FAS and FAS ligand genes and risk of skin cancer. J Dermatol Sci. 2010;58:78\u201380.","journal-title":"J Dermatol Sci"},{"key":"4295_CR15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2012.12.002","volume":"128","author":"Y Li","year":"2013","unstructured":"Li Y, Hao YL, Kang S, Zhou RM, Wang N, et al. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes. Gynecol Oncol. 2013;128:584\u20139.","journal-title":"Gynecol Oncol"},{"key":"4295_CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.urolonc.2010.05.006","volume":"30","author":"RK Mandal","year":"2012","unstructured":"Mandal RK, Mittal RD. Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population? Urol Oncol. 2012;30:555\u201361.","journal-title":"Urol Oncol"},{"issue":"19","key":"4295_CR17","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","volume":"19","author":"DK Lahiri","year":"1991","unstructured":"Lahiri DK, Nurnberger Jr JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19(19):5444.","journal-title":"Nucleic Acids Res"},{"key":"4295_CR18","doi-asserted-by":"crossref","unstructured":"Hu Z, Li C, Chen K, Wang LE, Sturgis EM, et al. Single nucleotide polymorphisms in selected apoptotic genes and BPDE-induced apoptotic capacity in apparently normal primary lymphocytes: a genotype-phenotype correlation analysis. J Cancer Epidemiol. 2008;1\u20138.","DOI":"10.1155\/2008\/147905"},{"key":"4295_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78\u201385.","journal-title":"N Engl J Med"},{"key":"4295_CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","volume":"66","author":"N Itoh","year":"1991","unstructured":"Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233\u201343.","journal-title":"Cell"},{"key":"4295_CR21","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1016\/S0021-9258(19)50076-X","volume":"267","author":"A Oehm","year":"1992","unstructured":"Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor\/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem. 1992;267:10709\u201315.","journal-title":"J Biol Chem"},{"issue":"12","key":"4295_CR22","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/eji.1830241221","volume":"24","author":"HW Behrmann","year":"1994","unstructured":"Behrmann HW, Krammer PH. Structure of the human APO-1 gene. Eur J Immunol. 1994;24(12):3057\u201362.","journal-title":"Eur J Immunol"},{"issue":"10","key":"4295_CR23","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/intimm\/6.10.1567","volume":"6","author":"T Takahashi","year":"1994","unstructured":"Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, et al. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol. 1994;6(10):1567\u201374.","journal-title":"Int Immunol"},{"key":"4295_CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13277-013-1048-9","volume":"35","author":"K Li","year":"2014","unstructured":"Li K, Wusheng L, Huawei Z, Li Z. Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis. Tumor Biol. 2014;35:351\u20136.","journal-title":"Tumor Biol"},{"key":"4295_CR25","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s13277-013-1339-1","volume":"35","author":"J Zeng","year":"2014","unstructured":"Zeng J, Yi F, Peiyu L. FAS \u22121377 A\/G polymorphism in breast cancer: a meta-analysis. Tumor Biol. 2014;35:2575\u201381.","journal-title":"Tumor Biol"},{"issue":"3","key":"4295_CR26","volume":"9","author":"Y Xu","year":"2014","unstructured":"Xu Y, Bangshun H, Rui L, Yuqin P, Tianyi G, et al. Association of the polymorphisms in the Fas\/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies. PLoS One. 2014;9(3), e90090.","journal-title":"PLoS One"},{"key":"4295_CR27","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1158\/1078-0432.CCR-08-1770","volume":"15","author":"LWK JaeYP","year":"2009","unstructured":"JaeYP LWK, Jung DK, Choi JE, Park JI, et al. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Clin Cancer Res. 2009;15:1794\u2013800.","journal-title":"Clin Cancer Res"},{"key":"4295_CR28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12253-013-9705-2","volume":"20","author":"V Behnaz","year":"2014","unstructured":"Behnaz V, Zahra A, Hossein G, Reza H, Fatemeh MK. Fas gene variants in childhood acute lymphoblastic leukemia and association with prognosis. Pathol Oncol Res. 2014;20:367\u201374.","journal-title":"Pathol Oncol Res"},{"issue":"6","key":"4295_CR29","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1158\/1055-9965.EPI-10-0030","volume":"19","author":"L Dapeng","year":"2010","unstructured":"Dapeng L, Erich MS, Wang LE, Zhensheng L, Mark E, et al. FAS and FASLG genetic variants and risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1484\u201391.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4295_CR30","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1158\/1078-0432.CCR-05-1739","volume":"12","author":"Z Zhang","year":"2006","unstructured":"Zhang Z, Wang LE, Erich MS, Adel KEN, Waun KH, et al. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006;12:5596\u2013602.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"4295_CR31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djh187","volume":"96","author":"T Sun","year":"2004","unstructured":"Sun T, Xiaoping M, Xuemei Z, Wen T, Ping X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst. 2004;96(13):1030\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"4295_CR32","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/srep03866","volume":"4","author":"H Zhao","year":"2014","unstructured":"Zhao H, Linfeng Z, Xinru L, Lifang W. FasL gene -844T\/C mutation of esophageal cancer in south China and its clinical significance. Sci Rep. 2014;4:3866. doi: 10.1038\/srep03866 .","journal-title":"Sci Rep"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4295-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4295-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4295-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T01:52:39Z","timestamp":1653529959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4295-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,13]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["4295"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4295-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,13]]}}}